1.Grasselli G, Calfee CS, Camporota L, et al: ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies. Intensive Care Med 49(7):727–759, 2023.doi:10.1007/s00134-023-07050-7
2.Frat JP, Thille AW, Mercat A, et al: High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure.N Engl J Med 372:2185–2196, 2015.doi: 10.1056/NEJMoa1503326
3.Patel BK, Wolfe KS, Pohlman AS, et al: Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome: A randomized clinical trial.J AMA 315(22):2435–2441, 2016.doi: 10.1001/jama.2016.6338
4.Grieco DL, Menga LS, Cesarano M, et al: Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients With COVID-19 and moderate to severe hypoxemic respiratory failure: The HENIVOT randomized clinical trial.JAMA 325(17):1731–1743, 2021.doi: 10.1001/jama.2021.4682
5.Bellani G, Laffey JG, Pham T, et al: Noninvasive ventilation of patients with acute respiratory distress syndrome.Insights from the LUNG SAFE study.Am J Respir Crit Care Med 195(1):67–77, 2017.doi: 10.1164/rccm.201606-1306OC
Demiselle J, Calzia E, Hartmann C, et al: Target arterial PO2 according to the underlying pathology: a mini-review of the available data in mechanically ventilated patients. Ann Intensive Care 11(1):88, 2021.doi:10.1186/s13613-021-00872-y
6.Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial (ART) Investigators, Cavalcanti AB, Suzumura ÉA, et al: Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: A randomized clinical trial.JAMA 318(14):1335–1345, 2017.doi: 10.1001/jama.2017.14171
7.Guérin C, Reignier J, Richard JC, et al: Prone positioning in severe acute respiratory distress syndrome.N Engl J Med 368(23):2159–2168, 2013.doi: 10.1056/NEJMoa1214103
8.Scholten EL, Beitler JR, Prisk GK, et al: Treatment of ARDS with prone positioning.Chest 151:215–224, 2017.doi: 10.1016/j.chest.2016.06.032.Epub 2016 Jul 8
9.National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, et al: Comparison of two fluid-management strategies in acute lung injury.N Engl J Med 354(24):2564–2575, 2006.doi: 10.1056/NEJMoa062200
10.Qadir N, Chang SY: Pharmacologic Treatments for Acute Respiratory Distress Syndrome. Crit Care Clin 37(4):877–893, 2021.doi:10.1016/j.ccc.2021.05.009
11.Lewis SR, Pritchard MW, Thomas CM, Smith AF: Pharmacological agents for adults with acute respiratory distress syndrome. Cochrane Database Syst Rev 7(7):CD004477, 2019.doi:10.1002/14651858.CD004477.pub3
12.Villar J, Ferrando C, Martinez D, et al: Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.Lancet Respir Med 8: 267–276, 2020.doi: 10.1016/S2213-2600(19)30417-5